Florida Cancer Specialists & Research Institute Research Breakthroughs Presented at Global Hematology Gathering
December 13, 2022 09:17 ET
|
Florida Cancer Specialists & Research Institute
Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) that is contributing to global advancements in the...
Aptose Announces Updated Clinical Responses, Breadth of Activity, and Safety Across Four Dose Levels of Tuspetinib in Difficult-to-Treat Acute Myeloid Leukemia Populations
December 11, 2022 09:00 ET
|
Aptose Biosciences, Inc.
Company Provides Comprehensive Clinical Update from Phase 1/2 TrialTuspetinib Continues to Deliver Single Agent Responses in r/r AML PatientsTuspetinib Safety and Efficacy Profile may Position Drug to...
International Myeloma Foundation Named Winner of 2022 Amazon Web Services IMAGINE Grant for Nonprofits
December 01, 2022 08:45 ET
|
International Myeloma Foundation
STUDIO CITY, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced it has been selected as a winner of the 2022 Amazon Web Services (AWS) IMAGINE...
In-Vitro Diagnostics Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
November 15, 2022 06:00 ET
|
Graphical Research
Pune, India, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The global in-vitro diagnostics market size is expected to witness remarkable growth during the forecast period, attributed to growing incidence of...
Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib
November 14, 2022 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting...
Global Plasma Fractionation Market Envisioned to Generate a Revenue of $45,803.2 Million and Grow at a CAGR of 7.0% during the Forecast Period from 2020 to 2027 [165-Pages] | Published by Research DIve
August 29, 2022 09:03 ET
|
Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global plasma fractionation market is anticipated to generate a revenue of $45,803.2 million...
Global In Vitro Diagnostics (IVD) Market to Generate USD 118.57 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
August 19, 2022 09:03 ET
|
Next Move Strategy Consulting
New York, Aug. 19, 2022 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the global in vitro diagnostics (IVD) market generated USD 86.51 billion in 2021, and...
Companion Animal Diagnostics Market Revenue to Cross $2.68Bn, Globally, by 2027 at 4.1% CAGR – Exclusive Report by The Insight Partners
July 28, 2022 09:30 ET
|
The Insight Partners
New York, July 28, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Companion Animal Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis by...
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring Minimal Residual Disease in Diffuse Large B-Cell Lymphoma
July 28, 2022 07:30 ET
|
Adaptive Biotechnologies
SEATTLE, July 28, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
Molecular International Prognostic Scoring System Developed for Myelodysplastic Syndromes
June 12, 2022 10:00 ET
|
MDS Foundation, Inc. (963786)
YARDVILLE, N.J., June 12, 2022 (GLOBE NEWSWIRE) -- Today, the MDS Foundation announced the development of a new prognostic scoring system, the IPSS-Molecular, that will significantly improve risk...